FDA Investigator Karen Emasley Joseph

Karen Emasley Joseph has conducted inspections on 126 sites in 5 countries as of 02 Apr 2009. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
126
Last Inspection Date:
02 Apr 2009
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Taiwan, United Kingdom of Great Britain and Northern Ireland, Germany, China
FDA Investigators that have inspected at least one site in common with Karen Emasley Joseph:
Alicia M Mozzachio, Althea A Williams, Amanda Dinaro, Amanda S Zorn, Ana L Kewes, Andrew A Leboeuf, Anna Flynn, Anthony F Lorenzo, Anthony R Ronga, Ashley L Reiber, Audrey Dela Cruz, Bradley J Maunder, Brian D Nicholson, Brian P Emanuel, Brittani N Franklin, Bruce H Mccullough, Bryan L Mcguckin, Burnell M Henry, Carl A Huffman, III, Carlyn L Ray, Carrie Ann Plucinski, CDR Sean T Creighton, Chad E Schmear, Chad J Whitwell, Charles L Larson, Charles L Zhou, Charlie P Booker, Chase S Baldwin, Cheryl A Kmiec, Chiang Syin, PhD, Christina A Miller, Christopher D Leach, Clotia Cabbey Mensah, Constantin Y Philopoulos, Creighton T Tuzon, Daniel B Arrecis, Daniel C Kearns, Daniel Kearns, Dariusz Galezowski, Darrell E Luedtke, David J Gasparovich, David Perkins, Debra D Devlieger, Debra I Love, Debra Lboyd Seale, Denarvis C Mendenhall, Denise L Burosh, Dolores Harper, Dr. Gang Wang, PhD, Dr. Guang Gao, PhD, Edward D Mcdonald, Elizabeth B Griffin, Elliot P Cowam, PhD, Emilie E Kahn, Emma R Schaefer, Enrico Joset Mangahis, Eric M Mueller, PharmD, Eric S Pittman, Gene D Arcy, Geraldine G Phipps, Goran Periz, PhD, Gregory R Dill, Gregson A Joseph, Helen B Ricalde, Humera T Khan, Jacqueline Mdiaz Albertini, Jacqueline S Warner, James D Planchon, James R Fleckenstein, James T Karpus, James W Plucinski, Jan B Welch, Janae D Price, Jason F Chancey, Jeanne J Chiu, Jeanne J Thai, Jeanne M Morris, Jennifer A D'angelo, Jennifer C Adams, Jennifer C Johnson, Jesse A Vazquez, Jessica L Burley, Joan A Loreng, Jocelyn C Turner, John M Seale, John Misock, Joseph A Morkunas, Joseph D Cooper, Joshua M Adams, Julie D Bringger, Kathleen B Swat, Kathleen S Tormey, Kelvin Cheung, Kevin P Regan, Kimberly Lewandowski Walker, Kristen E Szenderski, Kristin D Jarrell, Kujtim Sadiku, Kyran R Gibson, Lakisha M Williams, Lana K Waselewski, Larry F Hallberg, Latoya A Griffith, Lauren A Crivellone, Laurie A Haxel, Lee Terry Moore, Lequita M Mayhew, Leslie D Hintz, Lewis K Antwi, Liliya V Bubiy, Lillian M Starr, Lisa Hayka, Lisa Hornback, Lorelei S Jarrell, Maksim A Levenchuk, Marcia A Worley, Margaret Torres Vazquez, Maria Diaz, Mark E Frank, Mark I Kaspar, Martha T Olone, Mary A Millner, Maryam Tabatabaie, Matthew J Sienko, Matthew T Sanchez, Maureen C Melvin, Melanie G Warzala, Melanie W Pishnery, Michael A Lang, Michael D Robinson, Michael E Maselli, Michele L Glendenning, Min Chu Chen, Natasha R Johnson, Nibin Varghese, MS, Nicholas F Lyons, Nicholas P Diorio, Nicholas Z Lu, Nicole J Clausen, Nicole K Trudel, Nicole S Williams, Norman L Brown, Norman Wong, Omotunde O Osunsanmi, Pablo Alcantara, Paola S Barnett, Patricia A Mcilroy, Patrick E Gainer, Paula P Demichael, Phung Thien Nguyen, Prabhu P Raju, Pradip N Akolkar, Rachel T Evans, Rafael Padilla, Richard Jay Tucker, RS, Robert L Stevenson, Roberta W Cunningham, Rose Ashley, Rosemary Wood Sexton, Roshni J Patel, Russell K Riley, Ryan S Martin, Samuel W Labinjo, Sarah B Tanksley, Shafiq S Ahadi, Shalonda C Clifford, Shana L Williams, Simone E Pitts, Stefen D Mcmillan, Stephen D Eich, Steven J Lynn, Sullan, Susan A Zullo, PhD, Susan D Yuscius, Susan M Jackson, Susan P Bruederle, Susan W Ciani, Tamara Brey, Tara A Marshall, Tara C Alcazar, Thai T Duong, That Q Dang, Thomas J Arista, Thomas W Nojek, Timothy Brennan, Todd M Stankewicz, Todd Q Dang, Vaishali J Patel, Vioela J Caze, Vladimir Wolf, William G Nelson, William R Weissinger, Yehualashet A Gessesse, Zerita White

Karen Emasley Joseph's Documents

Publish Date Document Type Title
September, 2003 FDA 483 Healthcare-id, Inc. - Form 483, 2003-09-16
December, 2008 EIR Abbott Laboratories - EIR, 2008-12-11
January, 2006 EIR Abbott Molecular, Inc. - EIR, 2006-01-31
February, 2007 FDA 483 Abbott Molecular, Inc. - Form 483, 2007-02-21
January, 2006 FDA 483 Abbott Molecular, Inc. - Form 483, 2006-01-31
October, 2006 EIR Abbott Laboratories Diagnostic Division - EIR, 2006-10-27
November, 2003 EIR Abbott Laboratories - EIR, 2003-11-13
February, 2007 EIR Abbott Molecular, Inc. - EIR, 2007-02-21
September, 2003 EIR Medline Industries, LP (f/k/a Medline Industries, Inc.) - EIR, 2003-09-19
May, 2007 EIR Abbott Laboratories - EIR, 2007-05-02
July, 2006 FDA 483 MRL, Inc., A Welch Allyn Company - Form 483, 2006-07-20
March, 2006 FDA 483 CeramTec GmbH, Medical Products Division - Form 483, 2006-03-16
May, 2008 FDA 483 Response GE Healthcare - Form 483R, 2008-06-02
May, 2004 EIR Abbott Laboratories - EIR, 2004-05-12
December, 2002 FDA 483 Stereo Optical Co Inc - Form 483, 2002-12-12
July, 2005 FDA 483 Abbott Laboratories - Form 483, 2005-07-29
April, 2002 EIR Steris Isomedix Services - EIR, 2002-04-25
November, 2006 EIR Abbott Laboratories - EIR, 2006-11-09
April, 2009 FDA 483 Baxter Healthcare Corporation - Form 483, 2009-04-22
September, 2002 EIR Kaltron, Inc.; d.b.a. Kaltron-Pettibone - EIR, 2002-09-23
May, 2006 EIR Abbott Laboratories - EIR, 2006-05-16
November, 2004 EIR Abbott Laboratories - EIR, 2004-11-04
July, 2005 EIR Abbott Laboratories - EIR, 2005-07-15
July, 2008 FDA 483 Sage Products LLC - Form 483, 2008-07-10
May, 2005 EIR Syntec Scientific Corporation - EIR, 2005-05-05
May, 2008 FDA 483 GE Healthcare - Form 483, 2008-05-13
November, 2002 FDA 483 Hydrox Laboratories - Form 483, 2002-11-26
November, 2005 EIR Abbott Laboratories - EIR, 2005-11-10
May, 2005 FDA 483 Syntec Scientific Corporation - Form 483, 2005-05-05
May, 2008 EIR GE Healthcare - EIR, 2008-05-13
December, 2004 FDA 483 Harry J Bosworth Company - Form 483, 2004-12-22
July, 2003 FDA 483 Omron Healthcare, Inc. - Form 483, 2003-07-10
September, 2003 FDA 483 Medline Industries, LP (f/k/a Medline Industries, Inc.) - Form 483, 2003-09-19

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more